BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomita K, Teratani T, Yokoyama H, Suzuki T, Irie R, Ebinuma H, Saito H, Hokari R, Miura S, Hibi T. Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage. Dig Dis Sci. 2011;56:3648-3654. [PMID: 21674175 DOI: 10.1007/s10620-011-1771-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Himoto T, Tanaka N, Saito A, Muro Y, Sugiura K, Tani J, Miyoshi H, Morishita A, Yoneyama H, Haba R. Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients. Clin Res Hepatol Gastroenterol. 2015;39:222-229. [PMID: 25220385 DOI: 10.1016/j.clinre.2014.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Mouzaki M, Bramlage K, Arce-Clachar AC, Xanthakos SA. Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr 2018;67:631-4. [PMID: 30363043 DOI: 10.1097/MPG.0000000000002104] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Neuman MG, Cohen LB, Nanau RM. Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin Biochem. 2016;49:302-315. [PMID: 26188920 DOI: 10.1016/j.clinbiochem.2015.07.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
4 Almeida J, Polvorosa MA, Gonzalez-Quintela A, Madruga I, Marcos M, Pérez-Nieto MA, Hernandez-Cerceño ML, Orfao A, Laso FJ. Altered Distribution of Peripheral Blood Maturation-Associated B-Cell Subsets in Chronic Alcoholism. Alcohol Clin Exp Res 2015;39:1476-84. [PMID: 26146763 DOI: 10.1111/acer.12783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Armutcu F, Akyol S, Ucar F, Erdogan S, Akyol O. Markers in Nonalcoholic Steatohepatitis. Elsevier; 2013. pp. 67-125. [DOI: 10.1016/b978-0-12-407680-8.00004-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hendrikx T, Watzenböck ML, Walenbergh SM, Amir S, Gruber S, Kozma MO, Grabsch HI, Koek GH, Pierik MJ, Staufer K, Trauner M, Kalhan SC, Jonkers D, Hofker MH, Binder CJ, Shiri-Sverdlov R. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease. BMC Med 2016;14:107. [PMID: 27443391 DOI: 10.1186/s12916-016-0652-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
7 Napiórkowska-Baran K, Zalewska J, Jeka S, Dankiewicz-Fares I, Ziętkiewicz M, Szynkiewicz E, Kołtan S, Wawrzeńczyk A, Więsik-Szewczyk E, Bartuzi Z. Determination of antibodies in everyday rheumatological practice. Reumatologia 2019;57:91-9. [PMID: 31130747 DOI: 10.5114/reum.2019.84814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN. Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis. United European Gastroenterol J 2018;6:255-62. [PMID: 29511555 DOI: 10.1177/2050640617717156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Maleki I, Aminafshari MR, Taghvaei T, Hosseini V, Rafiei A, Torabizadeh Z, Barzin M, Orang E. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(35): 12566-12573 [PMID: 25253959 DOI: 10.3748/wjg.v20.i35.12566] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
10 Inamine T, Schnabl B. Immunoglobulin A and liver diseases. J Gastroenterol 2018;53:691-700. [PMID: 29075899 DOI: 10.1007/s00535-017-1400-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
11 Berglin L, Björkström NK, Bergquist A. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scand J Gastroenterol. 2013;48:719-728. [PMID: 23713804 DOI: 10.3109/00365521.2013.786131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]